BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16677779)

  • 1. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
    Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
    Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
    J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
    Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
    Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of ezrin in esophageal squamous cell carcinoma.
    Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
    J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.
    Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
    Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
    Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of heat shock proteins in osteosarcomas.
    Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK
    Pathology; 2010; 42(5):421-5. PubMed ID: 20632817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
    Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
    Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
    Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
    Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
    Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
    Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
    Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
    Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.